Skip to main content

Archived Comments for: The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial

Back to article

  1. Special Acknowledgement

    Sheraz Nazir, University of Leicester

    13 October 2014

    The authors would like to especially acknowledge the great effort and contribution of Lorraine Shipley as the Trial Manager of the REFLO-STEMI Trial.

    Competing interests

    None declared